CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 18.29
+0.17 (0.94%)
Jun 15, 2026, 4:09 PM HKT
CF PharmTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2.49 | 21.09 | 31.73 | -49.4 | -131.73 |
Depreciation & Amortization | 67.22 | 58.85 | 52.96 | 38.2 | 27.9 |
Other Amortization | 1.3 | 1.34 | 1.2 | 0.69 | 1.9 |
Loss (Gain) From Sale of Assets | 0.06 | 0.63 | 0.39 | 0.81 | 0.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | -0.3 |
Loss (Gain) From Sale of Investments | 2 | -7.05 | -8.68 | -7.99 | -13.35 |
Loss (Gain) on Equity Investments | 0.17 | 0.07 | 0.1 | - | - |
Stock-Based Compensation | 8.49 | 7.82 | 16.68 | 15.92 | 14.24 |
Provision & Write-off of Bad Debts | - | - | - | - | 0.06 |
Other Operating Activities | -7.19 | 1.82 | -8.22 | -27.41 | -4.86 |
Change in Accounts Receivable | -137.57 | -25.55 | 6.39 | -8.26 | -3.38 |
Change in Inventory | 8.8 | -12.97 | -10.66 | -8.51 | -15.99 |
Change in Accounts Payable | 2.42 | 7.43 | 0.18 | -5.97 | 31.27 |
Change in Unearned Revenue | -3.45 | -3.52 | 18.59 | -0.42 | - |
Change in Other Net Operating Assets | -55.03 | 46.5 | 15.64 | 97.81 | - |
Operating Cash Flow | -110.3 | 96.46 | 116.29 | 45.47 | -156.69 |
Operating Cash Flow Growth | - | -17.05% | 155.77% | - | - |
Capital Expenditures | -112.66 | -167.66 | -114.64 | -91.19 | -91.25 |
Sale (Purchase) of Intangibles | -38.47 | -32.99 | -23.7 | -15.74 | - |
Investment in Securities | 28.92 | 73.17 | 14.76 | -34 | 375.92 |
Other Investing Activities | 1.63 | 14.05 | -4.08 | -10.5 | 16.4 |
Investing Cash Flow | -120.58 | -113.44 | -127.65 | -151.42 | 301.06 |
Long-Term Debt Issued | 88.84 | 54.8 | 20 | - | - |
Long-Term Debt Repaid | -23.4 | -5.78 | -3.55 | -4.01 | - |
Net Debt Issued (Repaid) | 65.44 | 49.02 | 16.45 | -4.01 | - |
Issuance of Common Stock | 554.79 | - | - | - | - |
Repurchase of Common Stock | -2.09 | - | - | - | - |
Other Financing Activities | -49.94 | -20.33 | -8.58 | -1.4 | -4.5 |
Financing Cash Flow | 568.21 | 28.69 | 7.88 | -5.41 | -4.5 |
Foreign Exchange Rate Adjustments | -4.38 | -0.39 | -0.74 | 2.92 | -1.75 |
Net Cash Flow | 332.96 | 11.33 | -4.23 | -108.45 | 138.11 |
Free Cash Flow | -222.96 | -71.2 | 1.65 | -45.72 | -247.95 |
Free Cash Flow Margin | -51.55% | -11.72% | 0.30% | -13.10% | -590.55% |
Free Cash Flow Per Share | -0.59 | -0.19 | 0.00 | -0.12 | - |
Cash Interest Paid | 2.36 | 1.52 | - | - | - |
Cash Income Tax Paid | - | - | - | - | -15.79 |
Levered Free Cash Flow | -288.95 | -97.61 | 45.97 | -135.42 | -207.07 |
Unlevered Free Cash Flow | -287.37 | -96.49 | 46.07 | -135.32 | -206.98 |
Change in Working Capital | -184.82 | 11.89 | 30.14 | 74.65 | -50.57 |